ONCOTYPE DX AR-V7 NUCLEUS DETECT Trademark

Trademark Overview

On Monday, January 9, 2017, a trademark application was filed for ONCOTYPE DX AR-V7 NUCLEUS DETECT with the United States Patent and Trademark Office. The USPTO has given the ONCOTYPE DX AR-V7 NUCLEUS DETECT trademark a serial number of 87294342. The federal status of this trademark filing is REGISTERED as of Tuesday, June 12, 2018. This trademark is owned by Genomic Health, Inc.. The ONCOTYPE DX AR-V7 NUCLEUS DETECT trademark is filed in the Medical & Beauty Services & Agricultural Services category with the following description:

Medical testing for diagnostic and treatment purposes in the field of cancer research and disease classification; Providing medical information to medical professionals in the form of reports in the field of cancer and disease classification
oncotype dx ar-v7 nucleus detect

General Information

Serial Number87294342
Word MarkONCOTYPE DX AR-V7 NUCLEUS DETECT
Filing DateMonday, January 9, 2017
Status700 - REGISTERED
Status DateTuesday, June 12, 2018
Registration Number5493113
Registration DateTuesday, June 12, 2018
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, September 5, 2017

Trademark Statements

Pseudo MarkONCOTYPE DX AR-V SEVEN NUCLEUS DETECT
Goods and ServicesMedical testing for diagnostic and treatment purposes in the field of cancer research and disease classification; Providing medical information to medical professionals in the form of reports in the field of cancer and disease classification
Disclaimer with Predetermined Text"DX AR-V7 NUCLEUS DETECT"

Classification Information

International Class044 - Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, horticulture and forestry services.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateTuesday, January 17, 2017
Primary Code044
First Use Anywhere DateMonday, February 26, 2018
First Use In Commerce DateMonday, February 26, 2018

Trademark Owner History

Party NameGenomic Health, Inc.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressRedwood City, CA 94063
Party NameGenomic Health, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressRedwood City, CA 94063
Party NameGenomic Health, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressRedwood City, CA 94063

Trademark Events

Event DateEvent Description
Monday, June 12, 2023COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Friday, June 19, 2020APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Friday, June 19, 2020TEAS CHANGE OF CORRESPONDENCE RECEIVED
Friday, June 19, 2020ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Friday, June 19, 2020TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Friday, June 19, 2020TEAS CHANGE OF OWNER ADDRESS RECEIVED
Tuesday, June 12, 2018REGISTERED-PRINCIPAL REGISTER
Wednesday, May 9, 2018NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Tuesday, May 8, 2018ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Friday, March 23, 2018STATEMENT OF USE PROCESSING COMPLETE
Monday, March 5, 2018USE AMENDMENT FILED
Wednesday, March 21, 2018CASE ASSIGNED TO INTENT TO USE PARALEGAL
Monday, March 5, 2018TEAS STATEMENT OF USE RECEIVED
Tuesday, October 31, 2017NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, September 5, 2017OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, September 5, 2017PUBLISHED FOR OPPOSITION
Wednesday, August 16, 2017NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Wednesday, July 26, 2017APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, July 25, 2017EXAMINER'S AMENDMENT ENTERED
Tuesday, July 25, 2017NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Tuesday, July 25, 2017EXAMINERS AMENDMENT E-MAILED
Tuesday, July 25, 2017EXAMINERS AMENDMENT -WRITTEN
Wednesday, July 12, 2017TEAS/EMAIL CORRESPONDENCE ENTERED
Tuesday, July 11, 2017CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, July 11, 2017TEAS RESPONSE TO OFFICE ACTION RECEIVED
Friday, February 17, 2017NOTIFICATION OF NON-FINAL ACTION E-MAILED
Friday, February 17, 2017NON-FINAL ACTION E-MAILED
Friday, February 17, 2017NON-FINAL ACTION WRITTEN
Thursday, February 16, 2017NOTIFICATION OF NON-FINAL ACTION E-MAILED
Thursday, February 16, 2017NON-FINAL ACTION E-MAILED
Thursday, February 16, 2017NON-FINAL ACTION WRITTEN
Wednesday, February 1, 2017ASSIGNED TO EXAMINER
Sunday, January 22, 2017ASSIGNED TO EXAMINER
Wednesday, January 18, 2017NOTICE OF PSEUDO MARK E-MAILED
Tuesday, January 17, 2017NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Thursday, January 12, 2017NEW APPLICATION ENTERED

Related Keywords

detect nucleus oncotype medical cancer disease classification field information reports form professionals providing